Latest News

Markers of cognitive function in individuals with metabolic disease: Morquio syndrome and tyrosinemia type III

Blundell, J; Frisson, S; Chakrapani, A; Kearney, S; Vijay, S; MacDonald, A; Gissen, P; … Olson, A; + view all Blundell, J; Frisson, S; Chakrapani, A; Kearney, S; Vijay, S; MacDonald, A; Gissen, P; Hendriksz, C; Olson, A; – view fewer (2018) Markers of cognitive function in individuals with metabolic disease: Morquio syndrome and tyrosinemia type III. Cognitive Neuropsychology , 35 (3-4) pp. 120-147. 10.1080/02643294.2018.1443913 .

Source link




Related posts

New app can predict likelihood of developing incisional hernia after abdominal surgery

Newsemia

Why some human genes are more popular with researchers than others

Newsemia

Education RE: herd immunity can up readiness to be vaccinated

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy